Benzinga | Oct 26, 2021 05:01PM EDT

Usana Health Sciences Q3 EPS $1.36 Beats $1.30 Estimate, Sales $274.35M Beat $268.06M Estimate; Reaffirms FY21 Net Sales, EPS Guidance

Usana Health Sciences (NYSE:USNA) reported quarterly earnings of $1.36 per share which beat the analyst consensus estimate of $1.30 by 4.62 percent. This is a 5.56 percent decrease over earnings of $1.44 per share from the same period last year. The company reported quarterly sales of $274.35 million which beat the analyst consensus estimate of $268.06 million by 2.35 percent. This is a 8.09 percent decrease over sales of $298.51 million the same period last year.